| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 6.906 | 31.408 | 51.389 | 46.277 | 51.325 |
| Total Income - EUR | - | - | 0 | 0 | 0 | 6.906 | 31.408 | 51.389 | 46.277 | 51.325 |
| Total Expenses - EUR | - | - | 0 | 0 | 0 | 2.801 | 14.217 | 14.197 | 14.276 | 14.638 |
| Gross Profit/Loss - EUR | - | - | 0 | 0 | 0 | 4.105 | 17.191 | 37.192 | 32.002 | 36.687 |
| Net Profit/Loss - EUR | - | - | 0 | 0 | 0 | 4.035 | 16.876 | 36.677 | 31.539 | 35.147 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nutridiabclin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 44 | 43 | 42 | 5.318 | 18.167 | 37.967 | 32.887 | 37.029 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 2.595 | 8.955 | 27.635 | 30.512 | 25.250 |
| Cash | - | - | 44 | 43 | 42 | 2.723 | 9.212 | 10.331 | 2.375 | 11.778 |
| Shareholders Funds | - | - | 44 | 43 | 42 | 4.077 | 16.925 | 36.726 | 31.587 | 35.196 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 0 | 0 | 1.241 | 1.242 | 1.240 | 1.299 | 1.833 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nutridiabclin Srl